These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9221283)

  • 1. Some misconceptions about understanding autoimmunity through experiments with knockouts.
    Steinman L
    J Exp Med; 1997 Jun; 185(12):2039-41. PubMed ID: 9221283
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis.
    Frei K; Eugster HP; Bopst M; Constantinescu CS; Lavi E; Fontana A
    J Exp Med; 1997 Jun; 185(12):2177-82. PubMed ID: 9182689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis.
    Ruddle NH; Bergman CM; McGrath KM; Lingenheld EG; Grunnet ML; Padula SJ; Clark RB
    J Exp Med; 1990 Oct; 172(4):1193-200. PubMed ID: 2212948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT.
    Gommerman JL; Giza K; Perper S; Sizing I; Ngam-Ek A; Nickerson-Nutter C; Browning JL
    J Clin Invest; 2003 Sep; 112(5):755-67. PubMed ID: 12952924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor: a master-regulator of leukocyte movement.
    Sedgwick JD; Riminton DS; Cyster JG; Körner H
    Immunol Today; 2000 Mar; 21(3):110-3. PubMed ID: 10689296
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tumor necrosis factor and lymphotoxin: molecular genetics, regulation and physiological role].
    Nedospasov SA
    Genetika; 2003 Feb; 39(2):207-14. PubMed ID: 12669416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphogenic and host protective functions executed by tumor necrosis factor receptors, lymphotoxin receptors and their ligands.
    Pfeffer K
    Eur Cytokine Netw; 2000 Sep; 11(3):514. PubMed ID: 11203200
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of TNF and lymphotoxin on the hematopoietic system.
    Trinchieri G
    Immunol Ser; 1992; 56():289-313. PubMed ID: 1550864
    [No Abstract]   [Full Text] [Related]  

  • 9. Complementation of lymphotoxin alpha knockout mice with tumor necrosis factor-expressing transgenes rectifies defective splenic structure and function.
    Alexopoulou L; Pasparakis M; Kollias G
    J Exp Med; 1998 Aug; 188(4):745-54. PubMed ID: 9705956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetaminophen hepatotoxicity in tumor necrosis factor/lymphotoxin-alpha gene knockout mice.
    Boess F; Bopst M; Althaus R; Polsky S; Cohen SD; Eugster HP; Boelsterli UA
    Hepatology; 1998 Apr; 27(4):1021-9. PubMed ID: 9537442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphotoxin and tumor necrosis factor: qualitative and quantitative differences in their receptors and signal transduction in various cell types.
    Aggarwal BB
    Prog Clin Biol Res; 1990; 349():375-84. PubMed ID: 2169060
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor necrosis factor and lymphotoxin ligand-receptor system in lymphoproliferative disorders.
    Warzocha K; Salles G; Coiffier B
    Acta Haematol Pol; 1995; 26(4):323-32. PubMed ID: 8571733
    [No Abstract]   [Full Text] [Related]  

  • 13. A critical role for lymphotoxin in experimental allergic encephalomyelitis.
    Suen WE; Bergman CM; Hjelmström P; Ruddle NH
    J Exp Med; 1997 Oct; 186(8):1233-40. PubMed ID: 9334362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Functional analysis of non-HLA genes within MHC region with knockout-mouse technology].
    Matsumoto M
    Seikagaku; 1999 May; 71(5):323-32. PubMed ID: 10391982
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative analysis of the structure and function of TNF-alpha and TNF-beta.
    Aggarwal BB
    Immunol Ser; 1992; 56():61-78. PubMed ID: 1550876
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumour necrosis factor-alpha and lymphotoxin-alpha in the pathology of experimental autoimmune encephalomyelitis: is either one responsible or is there another ligand-mediating disease?
    Willenborg DO; Fordham SA; O'Brien NC; Cowden WB; Ramshaw IA
    Res Immunol; 1998; 149(9):804-10; discussion 849-50, 855-60. PubMed ID: 9923636
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphoid neo-organogenesis: lymphotoxin's role in inflammation and development.
    Ruddle NH
    Immunol Res; 1999; 19(2-3):119-25. PubMed ID: 10493167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biochemistry and pharmacology of TNF alpha and beta, 21 April 1995, New York.
    Carty TJ; Gilman SC
    Inflamm Res; 1995 Nov; 44(11):455-7. PubMed ID: 8597876
    [No Abstract]   [Full Text] [Related]  

  • 19. Turning off follicular dendritic cells.
    Mackay F; Browning JL
    Nature; 1998 Sep; 395(6697):26-7. PubMed ID: 9738494
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhanced sensitivity of tumor necrosis factor/lymphotoxin-alpha-deficient mice to Cryptococcus neoformans infection despite increased levels of nitrite/nitrate, interferon-gamma, and interleukin-12.
    Rayhane N; Lortholary O; Fitting C; Callebert J; Huerre M; Dromer F; Cavaillon JM
    J Infect Dis; 1999 Nov; 180(5):1637-47. PubMed ID: 10515827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.